Back to Search
Start Over
189PDTumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04).
- Source :
-
Annals of Oncology . 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. - Publication Year :
- 2018
- Subjects :
- *TRIPLE-negative breast cancer
*LYMPHOCYTES
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 29
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 133286048
- Full Text :
- https://doi.org/10.1093/annonc/mdy270.186